Marcus Muehlbauer, MD

Clinical Focus:
Inflammatory bowel diseases (Crohn’s disease and Ulcerative colitis).
Interplay of inflammatory bowel diseases and “functional” or irritable bowel syndrome.
Recurrent Clostridium difficile infections requiring “fecal transplant”.

Academic Interests:
Marcus has received funding from the Crohn’s and Colitis Foundation of America (CCFA) to investigate the role of the microbiota and innate sensors in the development of colitis-associated colon cancer. His work was cited more than 1200 times by other scientists, and his H index (measure for academic productivity) is 20.

Marcus will pursue a career in academics and his lab (starting 2014) will mainly work on a better understanding of how the microbiota affects intestinal stem cell regeneration and differentiation in inflammatory bowel diseases. His goal is to find new innovative treatment approaches for a subset of patients with IBD.

Publication Link

Education and Training

Degree Institution Area
MD University of Regensburg (Germany) Medicine


University of Regensburg (Germany) Experimental Internal Medicine
Residency/Fellowship University of Regensburg (German) Internal Medicine
Residency (USA) University of North Carolina at Chapel Hill Internal Medicine
Fellowship (USA) University of North Carolina at Chapel Hill Gastroenterology